Calzia R, Giacchino R, Marazzi M G, Ciravegna B, Navone C, Bertorello C, Lanteri M, Jannuzzi C
Boll Ist Sieroter Milan. 1986;65(1):1-5.
The authors have performed a longitudinal study of 118 children affected with B virus chronic hepatitis. Our first observation revealed 92 children with HBeAg positive (26 CPH, 66 CAH), 22 children with anti HBe positive (6CPH, 15 CAH, 1 cirrhosis), 4 children (CAH) with e/anti-e negative. A correlation between the severity of clinical forms and the behaviour of the e/anti-e system was not observed. Seroconversion was observed during the follow up period in 37 of 92 subjects in an average time of 59.83 +/- 32 months, time rather prolonged in patients under immunosuppressive therapy. To compare the clinical progress and the evolution of CPH and CAH respectively, always with regard to the e/anti-e system, statistically significant differences did not result. Only anti HBe positive recovered subjects, inclusive of seroconverted patients and those anti HBe from the first observation, showed significant results to the statistical analysis. Still, seroconversion corresponds frequently to a stable improvement of hepatitis. On the contrary evolution into cirrhosis was observed in 5 patients that had anti HBe antibodies.
作者对118例感染B型病毒慢性肝炎的儿童进行了一项纵向研究。我们的首次观察发现,92例儿童HBeAg阳性(26例慢性持续性肝炎,66例慢性活动性肝炎),22例抗-HBe阳性(6例慢性持续性肝炎,15例慢性活动性肝炎,1例肝硬化),4例(慢性活动性肝炎)e抗原/抗-e抗体均阴性。未观察到临床症状的严重程度与e抗原/抗-e抗体系统的表现之间存在相关性。在随访期间,92例受试者中有37例出现血清学转换,平均时间为59.83±32个月,免疫抑制治疗患者的时间较长。分别比较慢性持续性肝炎和慢性活动性肝炎的临床进展和演变情况,始终参照e抗原/抗-e抗体系统,未发现统计学上的显著差异。只有抗-HBe阳性的康复受试者,包括血清学转换患者和首次观察时即为抗-HBe阳性的患者,在统计分析中显示出显著结果。尽管如此,血清学转换通常对应着肝炎的稳定改善。相反,在5例有抗-HBe抗体的患者中观察到了肝硬化的进展。